CNTNAP2 and encephalitis: In patients with anti-LGI1/CASPR2-encephalitis, treatment studies should focus on specific symptoms, e.g. seizures and cognition (7, 17), or use more distinctive clinical scores like the Clinical Assessment Scale in Autoimmune Encephalitis (CASE) (18).